You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-ADAM12 antibody - Aminoterminal end catalytic domain (ab28225)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-ADAM12 antibody - Aminoterminal end catalytic domain
See all ADAM12 products (9) ...

Description

Rabbit polyclonal to ADAM12 - Aminoterminal end catalytic domain

Tested applications

WBmore details

Cross reactivity

Reacts with

Mouse, Human

Predicted to work with

Rat

Immunogen

Synthetic peptide based on the amino end of the catalytic domain of human ADAM 12.

(Peptide available as ab41205.)

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Storage buffer

Preservative: 0.05% Sodium Azide
Constituents: 50% Glycerol

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Clonality

Polyclonal

Isotype

IgG

  • Western blot - ADAM12 antibody - Aminoterminal end catalytic domain (ab28225)Western blot - ADAM12 antibody - Aminoterminal end catalytic domain (ab28225) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab28225 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • WB: Use at an assay dependent dilution. (A recommended starting concentration for Western blots is 1/1000 when using colorimetric substrates such as BCIP/NBT and 1/5000 for chemiluminescent substrates.)

Target

Function

Involved in skeletal muscle regeneration, specifically at the onset of cell fusion. Also involved in macrophage-derived giant cells (MGC) and osteoclast formation from mononuclear precursors.

Tissue specificity

Isoform 1 is expressed in placenta and skeletal, cardiac, and smooth muscle. Isoform 2 seems to be expressed only in placenta or in embryo and fetus. Both forms were expressed in some tumor cells lines. Not detected in brain, lung, liver, kidney or pancreas.

Sequence similarities

Contains 1 disintegrin domain.
Contains 1 EGF-like domain.
Contains 1 peptidase M12B domain.

Domain

The cysteine-rich domain supports cell adhesion through syndecans and triggers signaling events that lead to beta-1 integrin-dependent cell spreading. In carcinomas cells the binding of this domain to syndecans does not allow the integrin-mediated cell spreading.
The conserved cysteine present in the cysteine-switch motif binds the catalytic zinc ion, thus inhibiting the enzyme. The dissociation of the cysteine from the zinc ion upon the activation-peptide release activates the enzyme.

Post-translational
modifications

The precursor is cleaved by a furin endopeptidase.

Cellular localization

Secreted and Cell membrane.

Target information above from: UniProt accessionO43184 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • A disintegrin and metalloproteinase domain 12 antibody
  • A disintegrin and metalloproteinase domain 12 antibody
  • ADA12_HUMAN antibody
  • ADAM 12 antibody
  • ADAM metallopeptidase domain 12 antibody
  • ADAM12 antibody
  • Disintegrin and metalloproteinase domain-containing protein 12 antibody
  • MCMP antibody
  • MCMPMltna antibody
  • MCMPMltna antibody
  • Meltrin alpha antibody
  • Meltrin-alpha antibody
  • MLTN antibody
  • MLTNA antibody
  • OTTHUMP00000046766 antibody
see all

Anti-ADAM12 antibody - Aminoterminal end catalytic domain images:

  Western blot - ADAM12 antibody - Aminoterminal end catalytic domain (ab28225)

Western blot - ADAM12 antibody - Aminoterminal end catalytic domain (ab28225)

All lanes : Anti-ADAM12 antibody - Aminoterminal end catalytic domain (ab28225)

Lane 1 : Human LNCaP prostate cancer cells - whole cell lysate
Lane 2 : Human LNCaP prostate cancer cells - whole cell lysate

Lysates/proteins at 25 µg per lane.

Secondary
HRP donkey anti-rabbit polyclonal antibody
developed using the ECL technique

Performed under reducing conditions.

Observed band size : 68,92 kDa (why is the actual band size different from the predicted?)


Exposure time : 1 minute

This image is courtesy of an anonymous Abreview

See Abreview

References for Anti-ADAM12 antibody - Aminoterminal end catalytic domain (ab28225)

This product has been referenced in:

  • Zhang Let al. Adam12 plays a role during uterine decidualization in mice. Cell Tissue Res : (2009). WB; Mouse.Read more (PubMed: 19841944) »
  • Estrella Cet al. Role of A disintegrin and metalloprotease-12 in neutrophil recruitment induced by airway epithelium. Am J Respir Cell Mol Biol 41:449-58 (2009). Flow Cyt; Human.Read more (PubMed: 19213876) »

See all 2 publications for this product

Publishing research using ab28225? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"